RxDoctor Payments Data

Taylor Kasper, PA

Physician Assistant · Lexington, MINPI 1124547971

Payments from drug & device makers

$623in general payments, 2019–2025

Across 35 payments — averaging $17.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$202
  • Exact Sciences$108
  • AstraZeneca$94
  • Lilly USA, LLC$58
  • Xeris Pharmaceuticals, Inc.$48
  • AbbVie$32
  • plus $80 from 3 others

What the payments were for

  • Food & beverage$623100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$623 in reported general payments places this provider in the 65th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$98,860
Medicare patients
160
Services billed
3,882

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban67$79,516
MounjaroTirzepatide51$76,599
RinvoqUpadacitinib11$65,367
JardianceEmpagliflozin38$54,744
OzempicSemaglutide37$46,007
Trelegy ElliptaFluticasone/Umeclidin/Vilanter47$42,568
TrulicityDulaglutide13$23,752
XareltoRivaroxaban15$17,605
Combivent RespimatIpratropium/Albuterol Sulfate18$12,704
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$11,711
Fluticasone-SalmeterolFluticasone Propion/Salmeterol49$8,535
SymbicortBudesonide/Formoterol Fumarate18$6,580
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$5,576
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen257$5,517
Atorvastatin Calcium376$5,108

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$58$100,35164 claims
AbbVieRinvoq, Synthroid$32$66,37641 claims
Novo NordiskOzempic$202$46,00737 claims
GSKTrelegy Ellipta$22$42,56847 claims
AstraZenecaBreztri Aerosphere, Symbicort$94$18,29137 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Lexington

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →